Residue, distribution and depletion of fluralaner in egg following a single intravenous and transdermal administration in healthy shaver hens: fluralaner residue in egg [PDF]
: The demand for the use of fluralaner in an extra label manner is increasing due to lack of efficacious treatment to combat mites and bed bugs in the poultry industry in the United States.
James Yeatts +2 more
exaly +4 more sources
Fluralaner, a systemic pesticide, was originally registered with the US Food and Drug Administration in 2014 under the trade name Bravecto for flea treatment for pets.
Zhuoqi Liu +2 more
exaly +3 more sources
Distribution of fluralaner in plasma and liver in broiler breeder hens and roosters following the administration of fluralaner (Bravecto®) via medicated drinking water [PDF]
Bed bugs have become resistant to traditional insecticides, and the demand for effective drugs to eradicate bed bugs on poultry farms (especially table-egg layer) and breeder farms (especially broiler breeders) is growing. Fluralaner has been shown to be
Hiroko Enomoto +5 more
doaj +2 more sources
Ectoparasite infestations negatively affect both backyard and commercial chicken flocks in the United States. Fluralaner is an isoxazoline shown to be efficacious in treating mite and bed bug infestations in poultry. Fluralaner is approved to treat fleas
Baxter A Elliot +2 more
exaly +3 more sources
Long-term efficacy of fluralaner (Exzolt®) in Gallus gallus domesticus against epidemiologically relevant triatomines (Hemiptera: Reduviidae: Triatominae): a potential complementary strategy for Chagas disease control [PDF]
Background Chagas disease control relies primarily on vector control using pyrethroid insecticide sprays with residual action in domestic and peridomestic environments.
Luanderson Cardoso Pereira +18 more
doaj +2 more sources
A systematic review of fluralaner as a treatment for ectoparasitic infections in mammalian species [PDF]
Fluralaner (Bravecto™) is a novel isoxazoline ectoparasiticide used for controlling ectoparasites of domestic mammals and is increasingly being used on wildlife. The aim of this systematic review was to evaluate the efficacy, pharmacokinetics, and safety
Yuanting Jiang, Julie M. Old
doaj +3 more sources
Inhibitory Effect of Fluralaner on GABA Receptor Subunit RDL of Bactrocera dorsalis [PDF]
Bactrocera dorsalis (Hendel) (Diptera: Tephritidae), a highly destructive pest, affects fruits and vegetables globally, leading to significant economic losses.
Xiangyi Zhou +8 more
doaj +2 more sources
Pharmacokinetics and safety of topical fluralaner in koalas (Phascolarctos cinereus) [PDF]
Sarcoptic mange (etiological agent Sarcoptes scabiei) is among the most important parasitic diseases of some marsupial species and has been an emerging disease of koalas, causing welfare and conservation implications.
Ellyssia T. Young +10 more
doaj +2 more sources
Insecticidal activity of fluralaner (Exzolt®) administered to Gallus gallus domesticus against triatomines (Hemiptera, Reduviidae, Triatominae) [PDF]
Background Triatoma infestans, Triatoma brasiliensis, Triatoma pseudomaculata and Rhodnius prolixus are vectors of Trypanosoma cruzi, the etiological agent of Chagas disease. Chickens serve as an important blood food source for triatomines.
Luanderson Cardoso Pereira +12 more
doaj +2 more sources
Clinical efficacy and safety of a single administration of fluralaner injectable suspension (BRAVECTO® injectable) vs. monthly administration of oral afoxolaner (NexGard®) in dogs for tick and flea control over one year under European field conditions [PDF]
Background Year-round control of canine flea and tick infestations requires owner compliance with recommendations for regular treatments. Compliance failures can result in increased exposure of dogs to tick-borne pathogens and resurgence of flea ...
Ivo Petersen +8 more
doaj +2 more sources

